HEALTH

J&J recalls lots of Tylenol product over labeling

BY Allison Cerra

BOSTON — Johnson & Johnson recalled lots of its Tylenol Cold Multi-Symptom liquid products due to insufficient labeling, the company said Wednesday.

The products are not being recalled due to reports of any adverse events associated with taking the product, the company added.

Earlier this week, the company recalled additional lots of millions of packages of Children’s Benadryl and children’s Motrin.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

DRSI ReStore! Energy’s media campaign targets NYC

BY Allison Cerra

BOCA RATON, Fla. — Diabetica Research Solutions is spreading the word about its diabetes energy formula with a new media program that targets the New York metropolitan area.

The targeted media program for DRSI ReStore! Energy — which now is available at Duane Reade and Rite Aid pharmacies in the area — supplements the brand’s national television campaign, includes high saturation local commercial spots on television and radio, and internet banner ads to appear specifically on Web pages viewed by people in New York and the surrounding area.

"By supplementing our national television schedule with a locally targeted multimedia strategy, we can increase awareness of the brand DRSI ReStore! Energy, and expand our reach to many millions of people with diabetes," said Michael Dugan, DRSI marketing director.

DRSI ReStore! Energy is available at Kroger, Winn-Dixie, Giant Eagle, CVS.com, USA Drugs, Navarro Discount Pharmacies and more.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Industry organizations join forces to dispute new FDA restrictions

BY Alaric DeArment

COLORADO SPRINGS, Colo. Several organizations representing retailers and consumer healthcare product manufacturers want Congress to reverse a provision in the healthcare-reform act that would prohibit the use of flexible spending accounts to purchase over-the-counter medicines without a prescription.

The provision, part of the Patient Protection and Affordable Care Act, which President Obama signed into law in March, goes into effect Jan. 1. Organizations opposing the provision include the Global Market Development Center, a trade association representing suppliers, retailers and wholesalers of general merchandise, health, beauty and wellness products, as well as the National Association of Chain Drug Stores, the Consumer Healthcare Products Association and the National Grocers Association.

“The new FDA restrictions will add additional confusion [and] expense, and eliminate a benefit many consumers have come to depend upon to cost-effectively purchase medicines they need,” GMDC president and CEO Dave McConnell said in a statement. “Consumers depend on OTC medicines as a first line of defense for their families’ healthcare needs, and retail stores are in the business of providing remedies in an accessible, consumer-friendly way.”

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?